Alert detail
LCD L38043: MolDX: Plasma-Based Genomic Profiling in Solid Tumors — Palmetto GBA
What changed
Palmetto finalizes liquid biopsy coverage for solid tumors in 7 SE states.
Who’s affected: Oncology billing teams · Effective: March 6, 2025
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
This change affects 10 billing codes.
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.